Pulmonary Fibrosis Pipeline Pulmonary Fibrosis Companies include Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals, Regend Therapeutics, among others. According to DelveInsight’s latest evaluation, the global Pulmonary Fibrosis pipeline includes … Continue reading →

Obsessive Compulsive Disorder Market Obsessive Compulsive Disorder (OCD) companies include Biohaven Pharmaceuticals, AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, among others. DelveInsight’s report titled “Obsessive Compulsive Disorder Market Insights, Epidemiology, and … Continue reading →

Alcohol Use Disorder Pipeline Alcohol Use Disorder companies include Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others According to DelveInsight’s evaluation, the global Alcohol Use Disorder (AUD) … Continue reading →

Hepatocellular Carcinoma Pipeline Leading Hepatocellular Carcinoma companies involved in this space include Can-Fite BioPharma, Surface Oncology, Novartis Oncology, GlaxoSmithKline, CStone Pharmaceuticals, Chugai Pharmaceutical, and several others. DelveInsight’s latest report, “Hepatocellular Carcinoma Pipeline Insight 2026,” offers an extensive evaluation of the … Continue reading →

Esophageal Cancer Clinical Trials Esophageal Cancer Companies include OncoTherapy Science/Shionogi & Co., Oncolys BioPharma, Lyvgen Biopharma, Adlai Nortye Biopharma, NovaRock Biotherapeutics, Genmab, Genentech, Jiangsu Hengrui Medicine, Taiho Pharmaceutical, Mirati Therapeutics, Boehringer Ingelheim, and several others. DelveInsight’s latest report, “Esophageal Cancer … Continue reading →

Hemophilia Pipeline Prominent Hemophilia companies include Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, Freeline Therapeutics, BioMarin Pharmaceutical, Staidson Beijing BioPharmaceuticals, Pfizer, Sangamo Therapeutics, Amunix, Bioverativ, Novo Nordisk, and others.   DelveInsight’s latest report, “Hemophilia Pipeline Insight, 2026” offers a … Continue reading →

HER2-Negative Breast Cancer Clinical Trials HER2-Negative Breast Cancer companies include Genentech, CytomX Therapeutics, H3 Biomedicine, Regor Therapeutics, Immutep Limited, Merck & Co., Klus Pharma, Olema Pharmaceuticals, BeiGene, AstraZeneca, Janssen/Merck/GSK, Ono Pharmaceutical, Laekna Therapeutics, NanoMab, InSilico Medicine, TYK Medicine, Shanghai Pharmaceutical … Continue reading →